I agree that this site is using cookies. You can find further informations here.
X
Motola, Domenico
84  results:
Search for persons X
?
1

PAttern of drug use in PEdiatrics: An observational study i..:

Di Salvo, Marta ; Santi Laurini, Greta ; Motola, Domenico...
British Journal of Clinical Pharmacology.  90 (2024)  4 - p. 1050-1057 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Real-life safety profile of mRNA vaccines for COVID-19: An ..:

Santi Laurini, Greta ; Montanaro, Nicola ; Broccoli, Massimiliano..
Vaccine.  41 (2023)  18 - p. 2879-2886 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Comparative Safety Profiles of Oncology Biosimilars vs. Ori..:

Nikitina, Victoria ; Santi Laurini, Greta ; Montanaro, Nicola.
Cancers.  15 (2023)  14 - p. 3680 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Safety of COVID-19 vaccines in pregnancy: a VAERS based ana..:

Santi Laurini, Greta ; Montanaro, Nicola ; Motola, Domenico
European Journal of Clinical Pharmacology.  79 (2023)  5 - p. 657-661 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Safety profile of paediatric COVID‐19 vaccines: An analysis..:

Nikitina, Victoria ; Santi Laurini, Greta ; Montanaro, Nicola.
Acta Paediatrica.  112 (2023)  11 - p. 2426-2433 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Safety Profile of Molnupiravir in the Treatment of COVID-19..:

Santi Laurini, Greta ; Montanaro, Nicola ; Motola, Domenico
Journal of Clinical Medicine.  12 (2022)  1 - p. 34 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Level of therapeutic innovation from the registration studi..:

Motola, Domenico ; Santi Laurini, Greta ; Bonaldo, Giulia.
Journal of Clinical Pharmacy and Therapeutics.  47 (2022)  12 - p. 2130-2139 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Safety profile of hydroxychloroquine used off‐label for the..:

Motola, Domenico ; Bonaldo, Giulia ; Montanaro, Nicola
Fundamental & Clinical Pharmacology.  36 (2022)  6 - p. 1099-1105 , 2022
Link: https://doi.org/10.1111/..
 
?
9

Adverse Event Reporting with Immune Checkpoint Inhibitors i..:

Noseda, Roberta ; Bonaldo, Giulia ; Motola, Domenico..
Cancers.  13 (2021)  5 - p. 1131 , 2021
Link: https://doi.org/10.3390/..
 
?
10

Safety profile of chimeric antigen receptor T-cell immunoth..:

Bonaldo, Giulia ; Montanaro, Nicola ; AlbertoVaccheri.
European Journal of Clinical Pharmacology.  77 (2021)  8 - p. 1225-1234 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Removal of the EMA orphan designation upon request of the s..:

Montanaro, Nicola ; Bonaldo, Giulia ; Motola, Domenico
European Journal of Clinical Pharmacology.  77 (2021)  7 - p. 1057-1063 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Evaluation of the safety profile of rotavirus vaccines: a p..:

Bonaldo, Giulia ; Noseda, Roberta ; Ceschi, Alessandro..
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
13

On criteria to evaluate the therapeutic innovation of drugs:

Motola, Domenico ; Montanaro, Nicola
British Journal of Clinical Pharmacology.  87 (2020)  5 - p. 2403-2404 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Human papilloma virus vaccination in males: A pharmacovigil..:

Bonaldo, Giulia ; Montanaro, Nicola ; Vaccheri, Alberto.
British Journal of Clinical Pharmacology.  87 (2020)  4 - p. 1912-1917 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Direct‐acting oral anticoagulants and alopecia: The valuabl..:

Bonaldo, Giulia ; Vaccheri, Alberto ; Motola, Domenico
British Journal of Clinical Pharmacology.  86 (2020)  8 - p. 1654-1660 , 2020
Link: https://doi.org/10.1111/..
 
1-15